TY - GEN 
AU - Pacheco-Paez T.
AU - Montastruc F.
AU - Rousseau V.
AU - Chebane L.
AU - Lapeyre-Mestre M.
AU - Renoux C.
AU - Montastruc J.-L.
PY - 2020
SN - 8853185
UR - http://hdl.handle.net/10818/60146
AB - Background: Use of gabapentinoids is increasing. Following recent case reports, we investigated a putative risk of parkinsonism with pregabalin or gabapentin. Methods: A disproportionality analysis of 5,653,547 individual case safety reports in the...
LA - eng
PB - Movement Disorders
KW - Adverse drug reactions
KW - Drug safety
KW - Gabapentin
KW - Gabapentinoids
KW - Parkinsonism
KW - Pregabalin
TI - Parkinsonism associated with gabapentinoid drugs: A pharmacoepidemiologic study
DO - 10.1002/mds.27876
ER -